Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-22

Clinical Trial Update: Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing the effectiveness of controlled-release morphine for chronic neuropathic pain in individuals with spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (controlled-release) (morphine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Neuropathic Pain, Spinal Cord Injury | Phase 2 | Status: COMPLETED